Gaeta Renee 4

What Happened Renee Gaeta, Chief Financial Officer of Outset Medical, reported the sale of 17,672 shares of Outset Medical common stock on June 3, 2026. The shares were sold at $4.94 per share for total proceeds of approximately $87,300. This was a sale (not a purchase) and was executed to satisfy tax withholding obligations tied to vested RSUs, not as a discretionary investment decision.

Key Details

• Transaction date: 2026-06-03; filing date: 2026-06-05 (reported promptly).
• Price and amount: 17,672 shares sold at $4.94 per share; proceeds ≈ $87,300.
• Shares owned after transaction: Not specified in the summary provided in this request (see filed Form 4 for exact post-transaction holdings).
• Footnote: The sale was a "sell to cover" to satisfy tax withholding on the vesting of 32,856 RSUs granted June 10, 2025. The filing notes this was required to cover taxes and "does not represent a discretionary trade" (transaction code F).
• Transaction codes: S = Sale; F = Tax withholding/sell-to-cover.

Context Sell-to-cover transactions are common when restricted stock units vest; a portion of shares is sold automatically to cover tax withholding. Such sales are administrative and generally not an indicator of the insider’s view on the company’s prospects. For full details, consult the Form 4 filing (Accession 0001484612-26-000029).